Gastrointestinal disturbances, skin rashes, and bleeding are the most commonly reported adverse effects associated with clopidogrel therapy. Blood dyscrasias, including neutropenia, thrombotic thrombocytopenic purpura, and aplastic anemia, have also occurred. There have been reports of hepatitis and cholestatic jaundice. Blood-lipid concentrations may increase during long-term therapy.